Home › NDC Lookup › RxCUI directory › RxCUI 1810787

Esomeprazole strontium 49.3 MG Delayed Release Oral Capsule — RxCUI 1810787

RxNorm drug concept · Semantic clinical drug
RxCUI 1810787 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1810787
Official nameEsomeprazole strontium 49.3 MG Delayed Release Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Esomeprazole Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The IV form is used when you can't swallow or absorb oral medication — for example, if you're recovering from a procedure, having surgery, or are too unwell to take anything by mou...
  • Why am I getting esomeprazole through an IV instead of just taking a pill?
  • That depends on what it's being used for. For GERD with esophagitis, it's approved for up to 10 days via IV — and your team will move you to oral esomeprazole as soon as possible....
  • How long will I be on this IV medication?
📖 Read our full Esomeprazole Injection guide →

🕸️ Concept Web — How Esomeprazole strontium 49.3 MG Delayed Release O... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Esomeprazole strontium 49.3 MG Delayed Release Oral Capsule RxCUI 1810787

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Esomeprazole 283742
    • Esomeprazole strontium 1435522
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Esomeprazole Delayed Release Oral Capsule 606725
    • Esomeprazole strontium Delayed Release Oral Capsule 2646346
    • Esomeprazole Oral Product 1165149
    • Esomeprazole Pill 1165150
    • Esomeprazole strontium Oral Product 2660510
    • Esomeprazole strontium Pill 2660746
    • Delayed Release Oral Capsule 316995
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Esomeprazole strontium 49.3 MG 1810786

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Esomeprazole strontium 49.3 MG SCDC · 1810786
  • Esomeprazole Delayed Release Oral Capsule SCDF · 606725
  • Esomeprazole strontium Delayed Release Oral Capsule SCDFP · 2646346
  • Esomeprazole Oral Product SCDG · 1165149
  • Esomeprazole Pill SCDG · 1165150
  • Esomeprazole strontium Oral Product SCDGP · 2660510
  • Esomeprazole strontium Pill SCDGP · 2660746

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 1810787 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
70849-0200-30 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (70849-200-30) ESOMEPRAZOLE STRONTIUM R2 Pharma, LLC 2016-09-15
70849-0400-30 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (70849-400-30) ESOMEPRAZOLE STRONTIUM R2 Pharma, LLC 2016-09-15
Observed labelers: R2 Pharma, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.